China Infrastructure Construction Corp. (CHNC) Stock

About China Infrastructure Construction Corp.

China Infrastructure Construction Corp. (CHNC), founded in Houston, Texas, in 2003, is primarily an educational provider specializing in medical cannabis. The company delivers its cannabis-focused curricula throughout the United States and Latin America, also offering worldwide access via online platforms. Beyond its educational endeavors, CHNC furnishes a range of therapeutic services. These include the execution of clinical trials and the operation of a dedicated fertility and sleep center situated in Houston, Texas. This center specifically addresses sleep-related conditions, particularly those that result in infertility. Additionally, through its division, Pharmacology University, CHNC provides a comprehensive array of services related to medical cannabis, including instruction, advisory support, digital content creation, promotional activities, and licensing for franchise operations.

China Infrastructure Construction Corp. (CHNC) stock trades at $0.00 with a market capitalization of $5.04M. The stock is valued at a price-to-earnings (P/E) ratio of 0.03, price-to-book of -23.45, price-to-sales of 40.79.

On profitability, China Infrastructure Construction Corp. generates a return on equity (ROE) of 122.64% — well above the market average, a sign of a high-quality business, return on capital employed of 29.59%, an operating margin of -291.41%, a net profit margin of -229.04%.

Official website: www.chnc-hdh.com